Genetic health risks may arise due to assisted reproductive technology
Millions of children have been born as a result of assisted reproductive technologies since the birth of the first test tube baby in 1978.
Millions of children have been born as a result of assisted reproductive technologies since the birth of the first test tube baby in 1978.
The US Food and Drug Administration (FDA) has published a white paper on reducing the dose of radiation during imaging.
There is a surge in certain medical tests because of recent boom in medical technology.
SAS, the leader in business analytics software and services announced that Clinigene International Limited, a full-service Clinical Research Organization that partners with global pharmaceutical and biotechnology companies, has deployed SAS Clinical Data Management – PheedIt solution to accelerate clinical research.
Apollo Hospitals, all across the country are now covered in
ET Medical Devices, Italy, a highly specialised cardiac diagnostics Equipment Company is now a part of Trivitron Family.
Schiller India, a leading Swiss Joint Venture Company in the field of Medical Diagnostics, has launched a new MRI compatible monitor called MAGLIFE Serenity.
Anemia is the most common medical disorder in pregnancy having a high prence in developing countries like India.
An implantable device that monitors fluid build up in the lungs of heart failure patients and alerts doctors when intervention is needed can significantly reduce hospitalisations, according to a study published in The Lancet.
A 49-year-old woman has received the UK’s first totally implanted hearing aid, Otologics Carina, in a procedure performed at Queen Alexandra Hospital in Portsmouth.
Researchers have developed a device that can limit the side effects of chemotherapy.
The CARESTREAM PACS workstation was put through its paces at the recent 5th Scanner Volumique Conference held in Nancy, France. This annual event provides the technology platform for live demonstrations of the very latest versions of CT image post-processing software, which this year for the first time included a PACS console.
Researchers are developing a genetic test to predict prostate cancer aggressiveness, which could save men with low-risk tumours from unnecessary surgery.